Global Axial Spondyloarthritis (axSpA) Market 2023-2029
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global axial spondyloarthritis market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors approaches.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the commercialized therapies, indication, and region. The global market for axial spondyloarthritis can be segmented by commercialized therapies: anti-tumor necrosis factor therapy, anti-interleukin 17 therapy, anti-janus kinase therapy. Globally, the anti-tumor necrosis factor therapy segment made up the largest share of the axial spondyloarthritis market. Axial spondyloarthritis market is further segmented by indication: ankylosing spondylitis, non-radiographic axial spondyloarthritis (nr-axSpA). The ankylosing spondylitis segment captured the largest share of the market in 2022. Based on region, the axial spondyloarthritis market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. According to the research, North America had the largest share in the global axial spondyloarthritis market.
Market Segmentation
By commercialized therapies: anti-tumor necrosis factor therapy, anti-interleukin 17 therapy, anti-janus kinase therapy
By indication: ankylosing spondylitis, non-radiographic axial spondyloarthritis (nr-axSpA)
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The global axial spondyloarthritis market report offers detailed information on several market vendors, including Pfizer Inc., Johnson & Johnson Services, Inc., Novartis International AG, UCB S.A., Eli Lilly and Company, Kyowa Kirin Co., Ltd., Bristol-Myers Squibb Company, AbbVie Inc., Amgen Inc., Merck & Co., Inc., Takeda Pharmaceutical Company Limited, among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Scope of the Report
To analyze and forecast the market size of the global axial spondyloarthritis market.
To classify and forecast the global axial spondyloarthritis market based on commercialized therapies, indication, region.
To identify drivers and challenges for the global axial spondyloarthritis market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global axial spondyloarthritis market.
To identify and analyze the profile of leading players operating in the global axial spondyloarthritis market.
Why Choose This Report
Gain a reliable outlook of the global axial spondyloarthritis market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
PART 5. MARKET BREAKDOWN BY COMMERCIALIZED THERAPIES
Anti-tumor necrosis factor therapy
Anti-interleukin 17 therapy
Anti-janus kinase therapy
PART 6. MARKET BREAKDOWN BY INDICATION
Ankylosing spondylitis
Non-radiographic axial spondyloarthritis (nr-axSpA)
PART 7. MARKET BREAKDOWN BY REGION
North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America
PART 8. KEY COMPANIES
Pfizer Inc.
Johnson & Johnson Services, Inc.
Novartis International AG
UCB S.A.
Eli Lilly and Company
Kyowa Kirin Co., Ltd.
Bristol-Myers Squibb Company
AbbVie Inc.
Amgen Inc.
Merck & Co., Inc.
Takeda Pharmaceutical Company Limited
DISCLAIMER
Global Infectious Disease Testing Market Shares
2023 Global Infectious Disease Testing Market Shares in the US, Europe, and Japan--Competitive Analysis of Leading and Emerging Market Players This new report provides infectious diseases testing market shares for
USD 1850 View ReportGlobal Virology Bacteriology Parasitology and Mycology Testing Market in the US Europe and Japan
2023 Global Virology, Bacteriology, Parasitology and Mycology Testing Market in the US, Europe and Japan--2022 Supplier Shares by Test, 2022-2027 Segmentation Forecasts for 100 Respiratory, STD, Enteric, and other Microbiology
USD 18500 View ReportAxial Spondyloarthritis (Musculoskeletal) - Drugs in Development, 2021
Axial Spondyloarthritis (Musculoskeletal) - Drugs in Development, 2021Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Axial Spondyloarthritis - Drugs In Development, 2021, provides an overview of the Axial
USD 2000 View ReportGlobal Axial Flow Pumps Market Research Report 2021-2025
An axial-flow pump, or AFP, is a common type of pump that essentially consists of a propeller (an axial impeller) in a pipe. In the context of China-US trade war
USD 3200 View ReportFill The Form For Sample Request